Quarterly report pursuant to Section 13 or 15(d)

FORMATION AND REVERSE ACQUISITION OF MATINAS BIOPHARMA HOLDINGS - Formation (Details Textual)

v2.4.0.8
FORMATION AND REVERSE ACQUISITION OF MATINAS BIOPHARMA HOLDINGS - Formation (Details Textual) (Formation Of Holdings [Member], USD $)
 1 Months Ended
May 31, 2013
Formation And Reverse Acquisition [Line Items]  
Stock Issued During Period, Shares, New Issues 7,500,000
Warrants Issued For Purchase Of Common Stock 3,750,000
Common Stock To Be Issued Upon Exercise Of Warrants 3,750,000
Investment Warrants, Exercise Price $ 2.00
Proceeds from Issuance of Warrants $ 375,000
Stock And Warrants Issued, Price Per Unit 0.10
Adam Stern And Entities Owned By Stern [Member]
  
Formation And Reverse Acquisition [Line Items]  
Stock Issued During Period, Shares, New Issues 2,000,000
Common Stock To Be Issued Upon Exercise Of Warrants 1,000,000
Proceeds from Issuance or Sale of Equity, Total 375,000
Third Parties Including Certain Representatives Of Aegis Capital Corp [Member]
  
Formation And Reverse Acquisition [Line Items]  
Stock Issued During Period, Shares, New Issues 5,500,000
Warrants Issued For Purchase Of Common Stock 2,250,000
Common Stock To Be Issued Upon Exercise Of Warrants 2,250,000
Proceeds from Issuance of Warrants 75,000
Proceeds from Issuance or Sale of Equity, Total 375,000
Proceeds from Issuance of Common Stock 300,000
Formation Warrants [Member]
  
Formation And Reverse Acquisition [Line Items]  
Stock Issued During Period, Shares, New Issues 250,000
Warrants Issued For Purchase Of Common Stock 250,000
Investment Warrants, Exercise Price $ 2.00
Proceeds from Issuance or Sale of Equity, Total 10,000
Issuance Of Warrants Below Fair Value, Lower Price Than Fair Value Per Warrant 0.47
Issuance Of Equity Instruments Below Fair Value $ 108,316
Warrants Purchase Price 0.04